Skip to content

Effect of Mocotin spray on xerostomia and mucositis

Effect of Mocotin spray on cure of chemotherapy (Anthracycline) induced xerostomia and mucositis in breast cancer patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190708044149N2
Enrollment
60
Registered
2020-05-04
Start date
2020-12-01
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry mouth and mucositis caused by chemotherapy. Conjunctival xerosis, unspecified

Interventions

Intervention 1: Intervention group: Xerostomia patients with breast cancer receiving Mocotin spray every 2 hours a day and routine treatment (Nystatin Oral Suspension) for two weeks. Intervention 2:

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients women with Breast cancer Having at least 18 years and maximum 80 years Having mucositis Having xerostomia

Exclusion criteria

Exclusion criteria: Using of Alcohol and Drugs inhibit Salivation Radiation Therapy diseases such as Sogrene, rheumatoid arthritis, lupus; liver and kidney disease; major depression; diseases involving salivary glands such as diabetes; diseases causing dehydration such as chronic diarrhea, immune deficiency disorders, myelosuppression, diseases causing repeated oral aphthous Pregnancy

Design outcomes

Primary

MeasureTime frame
Xerostomia and Mucositis severity score based on eye scale criterion. Timepoint: Zero,1 and 2 weeks. Method of measurement: Xerostomia and mucositis Eye Scale Criterion Questionnaire.;Xerostomia and Mucositis severity score. Timepoint: Zero,1 and 2 weeks. Method of measurement: Xerostomia severity scale questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Ghazaleh Heydarirad

Shahid Beheshti University of Medical Sciences

ghazalrad@yahoo.com+98 21 8877 3521

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026